{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:29:14Z","timestamp":1791116954515,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.biologicals.2005.11.007","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T12:49:44Z","timestamp":1140612584000},"page":"227-231","source":"Crossref","is-referenced-by-count":12,"title":["CJD PrPsc removal by nanofiltration process: Application to a therapeutic immunoglobulin solution (Lymphoglobuline\u00ae)"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"Truchot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Perret-Liaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2005.11.007_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Sciences"},{"key":"10.1016\/j.biologicals.2005.11.007_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/66.1.109","article-title":"Prion protein conversion: insight into mechanisms, TSE transmission barriers and strains","volume":"66","author":"Caughey","year":"2003","journal-title":"Br Med Bull"},{"key":"10.1016\/j.biologicals.2005.11.007_bib3","first-page":"10962","article-title":"Conversion of \u03b1-helices into \u03b2-sheets features in the formation of the scrapie prion proteins","volume":"90","author":"Pan","year":"1993","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.biologicals.2005.11.007_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm883","article-title":"A prion epitope selective for the pathologically misfolded conformation","volume":"9","author":"Paramithiotis","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biologicals.2005.11.007_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt\u2013Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.biologicals.2005.11.007_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1246-7820(05)80044-8","article-title":"Viral safety of intravenous immunoglobulins G for therapeutic use","volume":"2","author":"Burnouf","year":"1995","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.biologicals.2005.11.007_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2516.2003.00701.x","article-title":"Nanofiltration of plasma-derived biopharmaceutical products","volume":"9","author":"Burnouf","year":"2003","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.biologicals.2005.11.007_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1423-0410.2003.00255.x","article-title":"Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies","volume":"84","author":"Wolf","year":"2003","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.biologicals.2005.11.007_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.2001.0269","article-title":"Scrapie removal using Planova\u00ae virus removal filters","volume":"29","author":"Tateishi","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2005.11.007_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1537-2995.2001.41040449.x","article-title":"A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma protein","volume":"41","author":"Lee","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2005.11.007_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-0934(99)00135-4","article-title":"Monitoring plasma processing steps with a sensitive western blot assay for the detection of prion protein","volume":"84","author":"Lee","year":"2000","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2005.11.007_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-0934(98)00113-X","article-title":"Sensitivity of the western blot detection of prion protein PrPres in natural sheep scrapie","volume":"75","author":"Madec","year":"1998","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2005.11.007_bib13","series-title":"Practice of disinfection. Preservation and sterilization","first-page":"222","article-title":"Transmissible degenerative encephalopathies: inactivation of the unconventional transmissible agents","author":"Taylor","year":"1998"},{"key":"10.1016\/j.biologicals.2005.11.007_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1348-0421.1991.tb01544.x","article-title":"Practical method for chemical inactivation of creutzfeldt\u2013Jakob disease pathogen","volume":"35","author":"Tateishi","year":"1991","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2005.11.007_bib15","first-page":"86","article-title":"Normal prion protein is found in human plasma, but is removed by SNBTS plasma fractionation process","volume":"82","author":"MacGregor","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biologicals.2005.11.007_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1423-0410.2000.7820086.x","article-title":"Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma protein","volume":"78","author":"Foster","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2005.11.007_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1423-0410.2003.00279.x","article-title":"Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process","volume":"84","author":"Trejo","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2005.11.007_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-3148.1999.009001003.x","article-title":"Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy","volume":"9","author":"Foster","year":"1999","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.biologicals.2005.11.007_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1423-0410.2003.00265.x","article-title":"Nanofiltration of single plasma donations: feasibility study","volume":"84","author":"Burnouf","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2005.11.007_bib20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(85)91576-4","article-title":"Creutzfeldt\u2013Jakob pathogen in growth hormone preparations is eliminatable","volume":"2","author":"Tateishi","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2005.11.007_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5360\/membrane.18.357","article-title":"Removal of causative agent of Creutzfeldt\u2013Jakob disease (CJD) trough membrane filtration method","volume":"18","author":"Tateishi","year":"1993","journal-title":"Membrane"},{"key":"10.1016\/j.biologicals.2005.11.007_bib22","series-title":"Animal cell technology: development towards the 21st century","first-page":"637","article-title":"Removal of the prion protein using validatable filter (BMM)","author":"Tateishi","year":"1995"},{"key":"10.1016\/j.biologicals.2005.11.007_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.2001.0269","article-title":"Scrapie removal using Planova\u00ae virus removal filters","volume":"29","author":"Tateishi","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2005.11.007_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1099\/vir.0.80389-0","article-title":"Type 1 and type 2 human PrPsc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt\u2013Jakob disease","volume":"86","author":"Kobayashi","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2005.11.007_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/biol.1996.0013","article-title":"Reduction of the infectivity of scrapie agent as a model for BSE in the manufacturing process of Trasylol","volume":"24","author":"Golker","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2005.11.007_bib26","first-page":"28","article-title":"A bovine spongiform encephalopathy validation study for aprotinin and bovine serum albumin","volume":"11","author":"Blum","year":"1998","journal-title":"Biopharm"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105605001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105605001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T01:52:15Z","timestamp":1555465935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105605001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1045105605001302"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2005.11.007","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}